NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 240 filers reported holding NEKTAR THERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,233,168 | +2.1% | 3,749,442 | -1.4% | 0.01% | 0.0% |
| Q2 2023 | $2,187,797 | +22.3% | 3,803,542 | +49.5% | 0.01% | +20.0% |
| Q1 2023 | $1,788,418 | +48.3% | 2,544,342 | +376.8% | 0.01% | +66.7% |
| Q4 2022 | $1,206,031 | -40.5% | 533,642 | -15.8% | 0.00% | -50.0% |
| Q3 2022 | $2,028,000 | +224.5% | 633,642 | +285.1% | 0.01% | +200.0% |
| Q2 2022 | $625,000 | -29.1% | 164,542 | +0.6% | 0.00% | 0.0% |
| Q1 2022 | $881,000 | -69.5% | 163,542 | -23.6% | 0.00% | -71.4% |
| Q4 2021 | $2,892,000 | +286.6% | 214,042 | +414.0% | 0.01% | +250.0% |
| Q3 2021 | $748,000 | +133.8% | 41,642 | +123.4% | 0.00% | +100.0% |
| Q2 2021 | $320,000 | -31.5% | 18,642 | -20.1% | 0.00% | 0.0% |
| Q1 2021 | $467,000 | +33.8% | 23,342 | +13.6% | 0.00% | 0.0% |
| Q4 2020 | $349,000 | -53.7% | 20,542 | -54.8% | 0.00% | -50.0% |
| Q3 2020 | $754,000 | +179.3% | 45,442 | +290.3% | 0.00% | +100.0% |
| Q2 2020 | $270,000 | -49.2% | 11,642 | -52.8% | 0.00% | 0.0% |
| Q4 2019 | $532,000 | +4.5% | 24,642 | +59.3% | 0.00% | 0.0% |
| Q4 2018 | $509,000 | -96.8% | 15,472 | -94.1% | 0.00% | -97.4% |
| Q3 2018 | $16,015,000 | +5.7% | 262,714 | -15.3% | 0.04% | -4.9% |
| Q2 2018 | $15,153,000 | +338.8% | 310,314 | +436.7% | 0.04% | +355.6% |
| Q4 2017 | $3,453,000 | +111.1% | 57,814 | -15.2% | 0.01% | +80.0% |
| Q3 2017 | $1,636,000 | +73.1% | 68,172 | +41.0% | 0.01% | +66.7% |
| Q2 2017 | $945,000 | -78.8% | 48,362 | -74.5% | 0.00% | -80.0% |
| Q1 2017 | $4,450,000 | +11.6% | 189,614 | -41.7% | 0.02% | 0.0% |
| Q4 2016 | $3,988,000 | -3.0% | 324,999 | +35.8% | 0.02% | -16.7% |
| Q3 2016 | $4,112,000 | +1876.9% | 239,367 | +1840.6% | 0.02% | +1700.0% |
| Q4 2015 | $208,000 | -61.6% | 12,335 | -64.7% | 0.00% | -75.0% |
| Q4 2014 | $542,000 | – | 34,977 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |